Sumihiro Maeda
Overview
Explore the profile of Sumihiro Maeda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1551
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Itsuno M, Tanabe H, Sano E, Sasaki T, Oyama C, Bannai H, et al.
Regen Ther
. 2025 Jan;
28():201-213.
PMID: 39811068
Introduction: Tau protein plays a pivotal role in the pathogenesis of Alzheimer's disease (AD) and in regulating neuronal excitability. Among tau-coding microtubule associated protein tau () gene mutations, the A152T...
2.
Maeda S, Djukic B, Taneja P, Yu G, Lo I, Davis A, et al.
EMBO Rep
. 2024 Oct;
25(11):5212-5215.
PMID: 39363060
No abstract available.
3.
Supakul S, Murakami R, Oyama C, Shindo T, Hatakeyama Y, Itsuno M, et al.
Inflamm Regen
. 2024 Feb;
44(1):8.
PMID: 38419091
Background: The development of induced pluripotent stem cells (iPSCs) technology has enabled human cellular disease modeling for inaccessible cell types, such as neural cells in the brain. However, many of...
4.
Supakul S, Oyama C, Hatakeyama Y, Maeda S, Okano H
Regen Ther
. 2024 Jan;
25:250-263.
PMID: 38293585
Introduction: 17β-Estradiol (E2) is a sex hormone that has been previously demonstrated to have neurotherapeutic effects on animal models of Alzheimer's disease (AD). However, clinical trials on E2 replacement therapy...
5.
Supakul S, Hatakeyama Y, Leventoux N, Itsuno M, Numata N, Hiramine H, et al.
Aging Brain
. 2023 Dec;
4:100101.
PMID: 38045491
Human neural cell models derived from induced pluripotent stem cells (iPSCs) have been widely accepted to model various neurodegenerative diseases such as Alzheimer's disease (AD) . Although the most common...
6.
Supakul S, Leventoux N, Tabuchi H, Mimura M, Ito D, Maeda S, et al.
Stem Cell Res
. 2022 May;
62:102802.
PMID: 35537244
Sporadic Alzheimer's disease (sAD) is a neurodegenerative disease that has the highest prevalence among patients with dementia. The genetic risk factors for sAD are comprised of many single nucleotide polymorphisms...
7.
Supakul S, Okano H, Maeda S
Front Aging Neurosci
. 2021 Nov;
13:768948.
PMID: 34803659
Alzheimer's disease (AD) is an aging-dependent neurodegenerative disease that impairs cognitive function. Although the main pathologies of AD are the aggregation of amyloid-beta (Aβ) and phosphorylated Tau protein, the mechanisms...
8.
Chen Y, Sakurai K, Maeda S, Masui T, Okano H, Dewender J, et al.
Stem Cell Reports
. 2021 Mar;
16(4):997-1005.
PMID: 33740463
The past decade has witnessed an extremely rapid increase in the number of newly established stem cell lines. However, due to the lack of a standardized format, data exchange among...
9.
Maeda S, Takashima A
Adv Exp Med Biol
. 2020 Feb;
1184:373-380.
PMID: 32096050
The accumulation of tau filaments in neurons is a pathological hallmark of various neurodegenerative diseases, including Alzheimer's disease. However, it is not the filamentous aggregates themselves, but non-filamentous tau species,...
10.
Nakamura M, Shiozawa S, Tsuboi D, Amano M, Watanabe H, Maeda S, et al.
Stem Cell Reports
. 2019 Sep;
13(4):684-699.
PMID: 31543469
Mutations in the microtubule-associated protein tau (MAPT) gene are known to cause familial frontotemporal dementia (FTD). The R406W tau mutation is a unique missense mutation whose patients have been reported...